U.S. Gas Utilities Stock News

If you have been wondering whether BioCryst Pharmaceuticals at around $7.57 is a bargain or a value trap, you are not alone. This article is aimed squarely at that question. Despite a choppy few years, the stock has edged up about 5.4% over the last month, while still roughly flat over the past year and well below levels from three years ago. That hints that sentiment might be cautiously shifting, but the long term story is still being debated. Recent headlines have focused on BioCryst's...

Wondering if Domino's Pizza is still a hot slice for your portfolio or if the best gains are already baked in? This breakdown will help you figure out what you are really paying for the stock today. Shares are up 3.6% over the last week and 6.9% over the past month, even though they are still slightly down at -0.7% year to date and -3.6% over the last year, which suggests sentiment is shifting after a softer stretch. Recently, investors have been reacting to Domino's ongoing push into tech...

Earlier this week, Gemini Space Station, Inc. announced that its affiliate Gemini Titan, LLC has received long-sought CFTC approval to operate as a Designated Contract Market, allowing it to launch regulated, event-based prediction markets for U.S. customers across areas such as crypto, elections, sports, and geopolitics. This five-year licensing journey marks Gemini’s entry into a tightly regulated prediction market arena previously dominated by a few incumbents, positioning its platform as...

Why Ingredion Stock Has Investors Taking a Second Look Ingredion (INGR) has quietly outperformed over the past 5 years, even as the stock has slid this year. That mix of long term strength and recent weakness now has value investors circling. See our latest analysis for Ingredion. Over the past year, Ingredion’s share price return has been negative as investors reassessed cyclical risks, yet its five year total shareholder return above 60% shows the longer term trend remains constructive...

Wondering if Vicor is still worth chasing after its big run, or if the smart move now is to sit tight and wait for a better entry point? Let us unpack what the market might be pricing in. The stock has climbed 1.0% over the last week, 3.7% over the past month, and is up an eye catching 102.8% year to date, after gaining 79.3% over the past year and 83.1% over three years, even though the five year return is a more modest 7.2%. Behind these moves, investors have been reacting to Vicor’s...

During the third quarter, New York City-based Summit Street Capital Management increased its Core Natural Resources stake by 81,170 shares, bringing its holding to 342,155 shares valued at about US$28.6 million and making the company its fourth-largest position. This sizeable addition by a major institutional investor highlights growing confidence in Core Natural Resources’ integrated mining-and-terminal model, capital return approach, and ability to preserve cash flow amid operational...

Recently, hedge fund Peconic Partners concentrated more than very large of its long exposure in infrastructure names including MasTec, betting on companies that build power lines and fiber networks underpinning AI and high-speed internet demand. This heightened institutional focus comes even as MasTec contends with a 12.9% gross margin and weaker free cash flow margins, highlighting how enthusiasm for AI-related infrastructure can outweigh near-term profitability concerns. We’ll now examine...

Trinity Capital (TRIN) just caught investor attention after two firms initiated bullish coverage on the stock, alongside better than expected third quarter earnings, with revenue jumping roughly 22% from a year earlier. See our latest analysis for Trinity Capital. Those upbeat initiations and the revenue surprise seem to be stabilizing sentiment, with the share price now at $15.18 and a 1 year total shareholder return of 19.2% signaling gradually building momentum despite recent quarterly...

If you are wondering whether Nextpower is still a smart buy after its huge run up, or if you have already missed the sweet spot, this article will walk through what the current price really implies. Despite pulling back around 4.2% over the last week and 10.1% over the past month, the stock is still up about 119.6% year to date and 144.6% over the last year. This naturally raises questions about whether the market has gotten ahead of itself. Recent headlines have focused on Nextpower...

Butler National (BUKS) has put up another solid quarter, with Q2 2026 revenue of about $23.3 million and net income of $6.0 million translating to basic EPS of roughly $0.09. This is underpinned by a trailing net profit margin of 19% and earnings growth of 29.2% over the past 12 months. The company has seen revenue move from around $21.4 million and EPS of about $0.05 in Q2 2025 to $23.3 million and $0.09 in Q2 2026, against a backdrop of five year compound earnings growth of 31.6%. This sets...

HCI Group (HCI) just picked up a more favorable Zacks Rank after analysts sharply raised their full year earnings forecasts, a shift in expectations that helps explain the stock’s strong year to date climb. See our latest analysis for HCI Group. The upgraded earnings outlook seems to be feeding into a powerful trend, with HCI’s share price climbing to $187.47 and delivering a roughly 64% year to date share price return, backed by a 3 year total shareholder return near 500%. This suggests that...

Incubator expansion puts Charles River in focus Charles River Laboratories International (CRL) has kicked off the second cohort of its Cell and Gene Therapy Incubator Program, spotlighting its role as an enabler for early stage biotech rather than a traditional contract research vendor. By opening its scientific talent, regulatory know how, and global lab footprint to six emerging therapy developers, the company is leaning into a partnership model that could deepen client stickiness and...

Recent performance sets the stage Intuitive Surgical (ISRG) has pulled back about 6% over the past week and roughly 5% over the past month, even though shares are still up more than 20% in the past 3 months. See our latest analysis for Intuitive Surgical. Zooming out, the recent pullback sits against a still impressive backdrop, with the 3 year total shareholder return more than doubling even as short term share price momentum has cooled around the current 542.32 dollars level. This hints at...

Earlier this week, Citizens Financial Group reported third-quarter results with revenue and earnings per share slightly above analyst expectations while its subsidiary Citizens Bank, N.A. lowered the prime lending rate from 7% to 6.75% effective 11 December 2025. This combination of a solid quarter and a rate cut aimed at easing borrowing costs highlights how Citizens is trying to balance profitability with support for customers amid changing financial conditions. Next, we’ll examine how...

Kimberly-Clark (KMB) has quietly slipped about 19% over the past 3 months, even as revenue and net income keep growing. That disconnect is exactly what makes the stock interesting right now. See our latest analysis for Kimberly-Clark. Zooming out, the 1 year total shareholder return of minus 18.25% and the year to date share price return of minus 21.04% tell a clear story of fading momentum despite steady fundamental progress. If Kimberly-Clark has you rethinking where defensiveness and...

If you are wondering whether Coca-Cola FEMSA. de is still good value after its strong run, or if most of the upside has already been priced in, you are not alone. The stock has climbed 3.1% over the last week, 4.1% over the last month, and is up 20.0% year to date. This builds on a 19.4% 1 year gain and gains of 55.0% and 146.8% over 3 and 5 years, respectively. Those gains have been supported by steady operational execution, continued strength in core Latin American beverage markets, and...

Rexford Industrial Realty (REXR) has quietly become a different kind of pandemic story, with its share price sliding about 50% even as its Southern California warehouses stay full and lease rates keep climbing. See our latest analysis for Rexford Industrial Realty. Over the past year, Rexford’s mid single digit total shareholder return and modest year to date share price gain at 41.28 dollars suggest sentiment is stabilising, not surging, as investors weigh reliable cash flows against higher...

Aon has recently reshaped its leadership bench, appointing Ben Jones as Asia Pacific COO in Singapore, expanding NFP’s complex risk team in the U.S., and naming veteran broker Richard “Dickie” Norman to its Global ReSpecialty property reinsurance team to advance its Risk Capital strategy. Together, these hires point to Aon concentrating expertise in property reinsurance and high‑growth regional and middle‑market segments, aligning its operations more closely with client demand for complex...

Wondering if DraftKings is still a smart bet at today’s price, or if most of the upside has already been cashed out? This breakdown is for you. The stock has bounced recently, up 4.5% over the last week and 12.7% over the past month, even though it is still down 2.1% year to date and 10.9% over the last year after a 193.1% gain across three years. That swingy performance has come as DraftKings doubles down on product innovation, expands its footprint into new regulated states, and continues...

Kaspi.kz recently reported Q3 2025 results showing 20% year-over-year revenue growth, strong fintech segment expansion, and progress toward launching its “Pay by Palm” biometric payment feature by year-end. This combination of solid financial performance and ongoing platform innovation highlights how Kaspi.kz is deepening its ecosystem while broadening future monetization avenues. We’ll now examine how Kaspi.kz’s strong Q3 fintech performance and upcoming “Pay by Palm” launch could shape its...

American International Group (AIG) has been quietly grinding higher, with the stock up about 10% over the past week and nearly 9% over the past month, outpacing broader insurance peers. See our latest analysis for American International Group. Zooming out, that strong 7 day and 30 day share price return comes on top of a solid year to date move and a healthy one year total shareholder return, suggesting momentum is building as investors warm to AIG’s improving fundamentals and...

In early December, JPMorgan analyst Samik Chatterjee reiterated an Overweight rating on Lumentum Holdings and cited stronger financial expectations for optical players, pointing to tightening supply-demand conditions and emerging opportunities in scale-across, multi-rail infrastructure and Optical Circuit Switches. Lumentum’s own outlook, including anticipated supply-driven price increases as demand outpaces supply and a push toward US$100 million in quarterly Optical Circuit Switch revenue...

Earlier this week, Texas Attorney General Ken Paxton announced that a district court issued a temporary restraining order blocking Johnson & Johnson and Kenvue from conducting business in Texas because they had been operating as unregistered foreign entities. The ruling highlights how compliance missteps around basic registration requirements can quickly escalate into operational constraints with potentially wide‑ranging legal and commercial consequences for Kenvue. We’ll now examine how...

If you have been wondering whether Northwest Bancshares is quietly turning into a value opportunity or just another sleepy regional bank, you are in the right place. The stock has nudged higher recently, up 4.7% over the last week and 7.7% over the past month, even though it is still slightly down year to date and over the last year. That uptick has come as investors refocus on regional banks that look relatively well positioned for a stabilizing rate environment and more predictable credit...